image credit- freepik
Singapore-based Esco Lifesciences Group has announced the acquisition of Allwin Medical Devices, Inc., a leading manufacturer of assisted reproductive technology (ART)/ in vitro fertilization (IVF) consumables in the US.
Allwin Medical will continue to operate under its established brand and will become a key pillar within Esco's Medical portfolio, alongside Esco Medical, further strengthening Esco's global position in reproductive medicine.
The acquisition reinforces Esco's strategy and commitment to deliver integrated ART/IVF workflow solutions, combining advanced equipment, time lapse imaging, high-quality consumables, digital traceability and witnessing, and AI-enabled embryo assessment and clinical support into a unified platform for fertility clinics worldwide.
Allwin Medical's operations and team will continue to play a central role in driving growth within Esco's Medical business unit. Headquartered in Anaheim, California, USA,and with Indian operation in Mumbai and Surat, Allwin Medical will serve as a key operating node and the India headquarters for Esco's Medical business unit, supporting further expansion in one of the world's fastest-growing healthcare markets.
